Trends in Biotechnology
Journal Title
- Trends in Biotechnology
ISSN
- E 1879-3096 | P 0167-7799 | 0167-7799 | 1879-3096
Publisher
- Elsevier BV
- Elsevier
Listed on(Coverage)
| JCR | 1997-2019 |
|---|---|
| SJR | 1999-2019 |
| CiteScore | 2011-2019 |
| SCI | 2010-2019 |
| SCIE | 2010-2021 |
| CC | 2016-2021 |
| SCOPUS | 2017-2020 |
| MEDLINE | 2016-2021 |
| EMBASE | 2016-2020 |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- ENGLAND
Aime & Scopes
- Trends in Biotechnology publishes reviews and perspectives on the applied biological sciences: useful science applied to, derived from, or inspired by living systems. The major themes that TIBTECH is interested in include /// Bioprocessing (biochemical engineering, applied enzymology, industrial biotechnology, biofuels, metabolic engineering) /// Omics (genome editing, single-cell technologies, bioinformatics, synthetic biology) /// Materials and devices (bionanotechnology, biomaterials, diagnostics/imaging/detection, soft robotics, biosensors/bioelectronics) /// Therapeutics (biofabrication, stem cells, tissue engineering and regenerative medicine, antibodies and other protein drugs, drug delivery) /// Agroenvironment (environmental engineering, bioremediation, genetically modified crops, sustainable development) We particularly seek articles that are relevant to more than one of these themes. Additionally, we welcome articles on law and intellectual property, policy and regulation, bioethics, scientific communication, and the economics of biotechnology. Reviews of mechanistic or phenomenological biology are generally not within TIBTECH's scope, although we do consider reviews of technologies developed from basic biology as long as there's an application in mind. TIBTECH has a diverse audience that reflects its intentionally broad scope. Our readers include not only biologists but also engineers, chemists, pharmacologists, computer scientists, and physicians, and they work in academic, clinical, industrial, NGO, and governmental settings. Therefore, we emphasize accessible articles that are easy to read, and we encourage authors to keep in mind that many readers may not be familiar with their field's specific terminology. For more of TIBTECH editor Matt Pavlovich's take on the journal's aims and scope, read his posts at CrossTalk, the Cell Press blog: What I talk about when I talk about biotechnology and A data-driven map of biotechnology.